H2020FP7HORIZON
Janssen Pharmaceutica NV
- Country
- BEBelgium
- Defence projects
- 0
- Projects, all programmes
- 131
- As coordinator
- 6
- EU contribution (CORDIS)
- EUR 10,443,749
- Active
- 2008 to 2025
Projects
131 projects, newest first
| Project | Programme | Year | Role | EU contribution |
|---|---|---|---|---|
| EPNDEuropean platform for neurodegenerative disorders | H2020 | 2021 | Participant | EUR 0 |
| ALLODDAllostery in Drug Discovery | H2020 | 2021 | Participant | EUR 256,320 |
| REALMENTUsing real-world big data from eHealth, biobanks and national registries, integrated with clinical trial data to improve outcome of severe mental disorders | H2020 | 2021 | Participant | EUR 502,169 |
| BEAMERBEhavioral and Adherence Model for improving quality, health outcomes and cost-Effectiveness of healthcaRe | H2020 | 2021 | Participant | EUR 0 |
| T2EVOLVEAccelerating Development and Improving Access to CAR and TCR-engineered T cell therapy | H2020 | 2021 | Participant | EUR 0 |
| COLOTANBoosting advanced doctoral training in innovative colon targeting drugs | H2020 | 2021 | Participant | EUR 256,320 |
| AIDDAdvanced machine learning for Innovative Drug Discovery | H2020 | 2021 | Participant | EUR 640,800 |
| UNITE4TBACADEMIA AND INDUSTRY UNITED INNOVATION AND TREATMENT FOR TUBERCULOSIS | H2020 | 2021 | Participant | EUR 0 |
| PharmaLedgerPharmaLedger | H2020 | 2020 | Participant | EUR 0 |
| SCORESwift COronavirus therapeutics REsponse | H2020 | 2020 | Participant | EUR 0 |
| ERA4TBEUROPEAN REGIMEN ACCELERATOR FOR TUBERCULOSIS | H2020 | 2020 | Participant | EUR 0 |
| PREMIERPrioritisation and Risk Evaluation of Medicines in the EnviRonment | H2020 | 2020 | Participant | EUR 0 |
| PAT4NanoProcess Analytical Technology Tools for Real-Time Physical and Chemical Characterization of Nanosuspensions | H2020 | 2020 | Participant | EUR 255,250 |
| CARECorona Accelerated R&D in Europe | H2020 | 2020 | Participant | EUR 0 |
| IDEA-FASTIdentifying Digital Endpoints to Assess FAtigue, Sleep and acTivities in daily living in Neurodegenerative disorders and Immune-mediated inflammatory diseases | H2020 | 2019 | Participant | EUR 0 |
| CompBioMed2A Centre of Excellence in Computational Biomedicine | H2020 | 2019 | Participant | EUR 169,000 |
| EU-PEARLEU Patient- cEntric clinicAl tRial pLatform | H2020 | 2019 | Participant | EUR 0 |
| RADAR-ADRemote Assessment of Disease and Relapse – Alzheimer’s Disease | H2020 | 2019 | Participant | EUR 0 |
| RespiriTBProgress new assets (one pre-new molecular entity and one first-time-in-human start) for tuberculosis that act synergistically with bedaquiline, cytochrome bc or cytochrome bd inhibitors | H2020 | 2019 | Participant | EUR 0 |
| Immune-ImageImmune-Image: Specific Imaging of Immune Cell Dynamics Using Novel Tracer Strategies | H2020 | 2019 | Participant | EUR 0 |
The country is the one the source records for the organisation’s registration (its PIC), and each profile says what it rests on. Where the record contradicts itself (the address in one country, the site name and the VAT number in another) we follow the two that agree: the Spanish research council CSIC is shown under Spain although its address is recorded in Italy. A body with sites in several countries is shown under the first of them in alphabetical order, and its profile lists the others. Beyond that we do not guess.
Where this comes from
- CORDIS: EU research projects (Horizon Europe, Horizon 2020, FP7)Last read on . Licence: Commission Decision 2011/833/EU (reuse of Commission documents). Source: CORDIS, European Commission.Participants and amounts as the Commission's CORDIS database states them (reuse under Commission Decision 2011/833/EU).
EU contribution is the amount CORDIS's open data pays to the participant. For a participant with linked third parties it may include their share (the CORDIS page prints the net); an amount the data does not hold is left out, not counted as zero. EDF factsheets state none per participant, so EDF projects count as projects but add nothing to the amounts.
Organisation-level facts only: a name, a country, a role, an amount, a year. A participant is recognised by its PIC where the source gives one, otherwise by name; the page says which. How the data is built.
Names are as CORDIS and the EDF project factsheets publish them. We do not list an organisation whose name looks like a natural person’s. If this entry is you, or a business named after you, and you want it removed, write to the contact in the imprint; the privacy notice (sections 7 and 9) says how a request is handled.